Literature DB >> 29804214

Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma.

Kenji Miyata1, Toshinori Hori2, Yasuto Shimomura2, Masahiro Joko3, Masakazu Takayasu3, Akihisa Okumura2.   

Abstract

CLINICAL CASE: We report on a 7-year-old female with spinal pilocytic astrocytoma complicated by pseudoprogression 1 month after completion of radiation therapy. Although she was initially treated with high-dose steroids, her clinical symptoms did not completely resolve, and magnetic resonance imaging (MRI) revealed extension of the lesions into the medulla oblongata. Treatment with bevacizumab was commenced, followed by rapid resolution of the clinical symptoms and improvements in the MRI findings.
CONCLUSION: This case highlights the efficacy and tolerability of bevacizumab for the treatment of pseudoprogression in children with spinal low-grade gliomas.

Entities:  

Keywords:  Bevacizumab; Pilocytic astrocytoma; Pseudoprogression; Steroid; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2018        PMID: 29804214     DOI: 10.1007/s00381-018-3841-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  14 in total

1.  Spinal cord pilocytic astrocytoma with cranial meningeal metastases.

Authors:  H K Ng; C H Leung; R Boet; W S Poon
Journal:  J Clin Neurosci       Date:  2001-07       Impact factor: 1.961

Review 2.  Effects of radiation on cerebral vasculature: a review.

Authors:  M M O'Connor; M R Mayberg
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

3.  Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.

Authors:  Kimberly A Foster; William J Ares; Ian F Pollack; Regina I Jakacki
Journal:  Pediatr Blood Cancer       Date:  2014-11-08       Impact factor: 3.167

4.  Spurious progression in pediatric brain tumors.

Authors:  Sheema Chawla; David N Korones; Michael T Milano; Ali Hussain; Abdel R Hussien; Ann G Muhs; Manisha Mangla; Howard Silberstein; Sven Ekholm; Louis S Constine
Journal:  J Neurooncol       Date:  2012-01-12       Impact factor: 4.130

5.  Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown.

Authors:  M N Tsao; Y Q Li; G Lu; Y Xu; C S Wong
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

6.  Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients.

Authors:  F J Epstein; J P Farmer; D Freed
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

7.  Mortality is higher in patients with leptomeningeal metastasis in spinal cord tumors.

Authors:  Ricardo de Amoreira Gepp; José Mauro Cardoso Couto; Maria Dorvalina da Silva; Marco Rolando Sainz Quiroga
Journal:  Arq Neuropsiquiatr       Date:  2013-01-08       Impact factor: 1.420

8.  Pseudoprogression of low-grade gliomas after radiotherapy.

Authors:  Robert P Naftel; Ian F Pollack; Giulio Zuccoli; Melvin Deutsch; Regina I Jakacki
Journal:  Pediatr Blood Cancer       Date:  2014-09-11       Impact factor: 3.167

9.  Phase II trial of conformal radiation therapy for pediatric low-grade glioma.

Authors:  Thomas E Merchant; Larry E Kun; Shengjie Wu; Xiaoping Xiong; Robert A Sanford; Frederick A Boop
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

10.  Cerebral radiation necrosis in pediatric patients.

Authors:  S Reed Plimpton; Nicholas Stence; Molly Hemenway; Todd C Hankinson; Nicholas Foreman; Arthur K Liu
Journal:  Pediatr Hematol Oncol       Date:  2013-05-07       Impact factor: 1.969

View more
  2 in total

1.  Primary spinal pilocytic astrocytoma: clinical study with long-term follow-up in 16 patients and a literature review.

Authors:  Yong Jiang; Liang Lv; Senlin Yin; Peizhi Zhou; Shu Jiang
Journal:  Neurosurg Rev       Date:  2019-05-16       Impact factor: 3.042

Review 2.  Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.

Authors:  Timothy K Nguyen; James Perry; Arun N E Sundaram; Jay Detsky; Pejman J Maralani; Eirena Calabrese; Sunit Das; Arjun Sahgal
Journal:  J Neurooncol       Date:  2019-05-03       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.